Comment on “Sodium glucose cotransporter 2 inhibitors and gout risk”

被引：0
|
作者：
Shih-Wei Lai
Bing-Fang Hwang
Chiu‑Shong Liu
Kuan-Fu Liao
机构：
[1] China Medical University,College of Medicine
[2] China Medical University Hospital,Department of Family Medicine
[3] China Medical University,Department of Occupational Safety and Health, College of Public Health
[4] Tzu Chi University,College of Medicine
[5] Taichung Tzu Chi Hospital,Division of Hepatogastroenterology, Department of Internal Medicine
来源：
Clinical Rheumatology | 2024年 / 43卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：835 / 836
页数：1
相关论文
共 50 条
  • [41] Sodium-glucose cotransporter 2 inhibitors and cardiovascular outcomes
    Steinberg, Helmut O.
    POSTGRADUATE MEDICINE, 2016, 128 (04) : 398 - 408
  • [42] Sodium/Glucose Cotransporter 2 Inhibitors and Magnesium Homeostasis: A Review
    Shah, Chintan, V
    Sparks, Matthew A.
    Lee, Chien-Te
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (05) : 648 - 658
  • [43] Benefits and Complications of Sodium-Glucose Cotransporter 2 Inhibitors
    Sangiovanni, Ryan J.
    DeVee, Carley E.
    US PHARMACIST, 2019, 44 (02) : HS9 - HS12
  • [44] Lipid effects of sodium-glucose cotransporter 2 inhibitors
    Lazarte, Julieta
    Kanagalingam, Tharsan
    Hegele, Robert A.
    CURRENT OPINION IN LIPIDOLOGY, 2021, 32 (03) : 183 - 190
  • [45] Sodium-Glucose Cotransporter 2 Inhibitors and Cardiac Remodeling
    Salah, Husam M.
    Verma, Subodh
    Santos-Gallego, Carlos G.
    Bhatt, Ankeet S.
    Vaduganathan, Muthiah
    Khan, Muhammad Shahzeb
    Lopes, Renato D.
    Al'Aref, Subhi J.
    McGuire, Darren K.
    Fudim, Marat
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2022, 15 (05) : 944 - 956
  • [46] Advantages of therapy with sodium glucose cotransporter type 2 inhibitors in patients with type 2 diabetes mellitus in combination with hyperuricemia and gout
    Panevin, T. S.
    Eliseev, M. S.
    Shestakova, M., V
    Nasonov, E. L.
    TERAPEVTICHESKII ARKHIV, 2020, 92 (05) : 110 - 118
  • [47] Repurposing antidiabetic medications for gout: the potential of sodium glucose co-transporter 2 inhibitors Comment
    Neogi, Tuhina
    LANCET RHEUMATOLOGY, 2019, 1 (04): : E197 - E199
  • [48] Characterization of Risk Factors for Genitourinary Infections with Sodium-Glucose Cotransporter-2 Inhibitors
    Benjamin, Trisha
    Schumacher, Christine
    PHARMACOTHERAPY, 2020, 40 (10): : 1002 - 1011
  • [49] Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of AKI in Older Adults with Type 2 Diabetes
    Zhuo, Min
    Paik, Julie M.
    Wexler, Deborah J.
    Bonventre, Joseph V.
    Kim, Seoyoung C.
    Patorno, Elisabetta
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 132 - 133
  • [50] Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Water and Sodium Metabolism
    Tang, Jun
    Ye, Lifang
    Yan, Qiqi
    Zhang, Xin
    Wang, Lihong
    FRONTIERS IN PHARMACOLOGY, 2022, 13
12345